Not Yet RecruitingNot Applicable

Posıtıve Psychology-Based Art Therapy In Hospıtalızed Chıldren

80 participantsStarted 2026-09-14

Plain-language summary

Pediatric hospitalization is known to be associated with negative developmental and psychosocial outcomes for child patients. Art therapy is a way to directly address the emotional world of hospitalized children. This research is significant both scientifically and clinically as an innovative intervention aimed at reducing the negative effects of pediatric hospitalization on the psychosocial and emotional development of children. It is believed that the research will contribute to a holistic approach to nursing care and lead to the development of scientifically based interventions in clinical practice. Furthermore, this research will provide nurses with evidence-based information that can guide them in implementing and evaluating self-compassion and empathy-focused care strategies that support children's psychosocial well-being. In this respect, the research directly contributes to nursing practice and provides transferable outcomes. This research was planned to examine the effect of positive psychology-based art therapy on self-compassion and hope levels in children aged 8-12 years hospitalized in a pediatric ward. The research will be conducted as a single-blind, randomized controlled experimental study with a pre-test, post-test design at Süleyman Demirel University Research and Application Hospital between June and December 31, 2026. Prior to the research, permission will be obtained from the scale administrators, participants, parents, ethics committee, and the institution. The sample will consist of 80 individuals (40 in the intervention group and 40 in the control group) who meet the inclusion criteria, are selected using simple randomization, and provide informed consent. The control group will receive no intervention; the pre-test will be administered on the first day, and the post-test on the day the intervention for the experimental group ends. The intervention group will receive art therapy three days a week for a total of five sessions; the pre-test will be administered on the first day, and the post-test on the last session. Data will be collected using the Personal Information Form (PIF) (Appendix 2), the Children's Hope Scale (CHS), and the Children's Self-Compassion Scale (CSCS). Data will be analyzed using the SPSS (Statistical Program for Social Sciences) statistical analysis software package, and statistical significance will be accepted as p \<0.05.

Who can participate

Age range

8 Years – 12 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Children aged 8-12 years receiving inpatient treatment in the pediatric ward. * Children hospitalized in the internal medicine units of the pediatric ward (diagnosed with Type 1 diabetes, Crohn's disease, ulcerative colitis, leukemia, enzyme deficiency, etc.) * The patient must be conscious, able to communicate verbally, and participate in the procedures. * Parental and child consent must be obtained. Exclusion Criteria: * The child's unwillingness to participate * Children with acute neurological disorders, confusion, or communication difficulties. * Children hospitalized in the surgical unit of the pediatric ward * Patients in intensive care or isolation rooms. * Children with severe psychiatric diagnoses (such as psychotic disorders, severe depression). * The child having a health problem that prevents their participation in the intervention.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Self-Compassion Scale for Children (SCS)

Timeframe: Baseline and immediately after completion of the intervention (2 weeks)

Children's Hope Scale (CHS)

Timeframe: Baseline and immediately after completion of the intervention (2 weeks)

Trial details

NCT IDNCT07735364

SponsorSuleyman Demirel University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-02-26

View on ClinicalTrials.gov More Pediatric trials